NCT06224244View on ClinicalTrials.gov

External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2027

Conditions
Breast NeoplasmsBreast Cancer
Interventions
RADIATION

Ten-fraction hypofractionated breast radiotherapy with 40 Gy simultaneous integrated bed boost

Patients undergo BCS followed by ten-fraction adjuvant breast irradiation (34Gy) with a risk adapted SIB dose of 40 Gy

RADIATION

Ten-fraction hypofractionated breast radiotherapy with 43 Gy simultaneous integrated bed boost

Patients undergo BCS followed by ten-fraction adjuvant breast irradiation (34Gy) with a risk adapted SIB dose of 43 Gy

Trial Locations (1)

00144

Regina Elena Cancer Institute, Rome

All Listed Sponsors
lead

Regina Elena Cancer Institute

OTHER